Sign In

Topics

Topics

Types

  • PSMO 20TH MIDYEAR CONVENTION

    Switch from Biological to Biosimilar: Efficacy and Safety Evidences of Rituximab Biosimilar

    June 18, 2022
    View Event

  • PSMO 20TH MIDYEAR CONVENTION

    Real world patient experience with PARP inhibitor, Olaparib in BRCA-mutated and non- BRCA mutated Ovarian Cancer

    June 17, 2022
    View Event

  • PSMO 20TH MIDYEAR CONVENTION

    All about Innovation

    June 17, 2022
    View Event

  • PSMO 20TH MIDYEAR CONVENTION

    Bevacizumab Biosimilar: Clinical and Scientific Considerations

    June 17, 2022
    View Event

  • PSMO 20TH MIDYEAR CONVENTION

    Confident Conversations on CDK4/6i

    June 16, 2022
    View Event